Page last updated: 2024-12-06
tibenelast
Description
Tibonelast is a synthetic compound with a complex chemical structure that was developed as a potential therapeutic agent for various medical conditions. Research has focused on its potential effects on inflammation, pain, and certain types of cancer. Its unique chemical properties have made it a subject of interest in drug development, and ongoing studies are aimed at further understanding its mechanisms of action and potential therapeutic applications. The synthesis of tibenelast involves a multi-step process, and its exact mechanism of action is still being elucidated. However, preliminary studies suggest that it may exert its effects by modulating specific cellular pathways involved in inflammation and pain signaling. The potential for tibenelast to be used as a therapeutic agent is being investigated in clinical trials. However, further research is required to assess its safety, efficacy, and optimal dosage for various medical conditions.'
tibenelast: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 59913 |
| CHEMBL ID | 2111055 |
| SCHEMBL ID | 449748 |
| MeSH ID | M0175931 |
Synonyms (22)
| Synonym |
|---|
| benzo(b)thiophene-2-carboxylic acid, 5,6-diethoxy- |
| tibenelastum [latin] |
| tibenelast [inn] |
| h051v8lj93 , |
| 97852-72-7 |
| tibenelastum |
| tibenelast |
| 5,6-diethoxybenzo(b)thiophene-2-carboxylic acid |
| unii-h051v8lj93 |
| tibenclast |
| nsc108930 |
| nsc-108930 |
| 5,6-diethoxy-1-benzothiophene-2-carboxylic acid |
| SCHEMBL449748 |
| PDUXMHXBBXXJFQ-UHFFFAOYSA-N |
| 5,6-diethoxybenzothiophene-2-carboxylic acid |
| CHEMBL2111055 |
| DTXSID10243289 |
| AKOS030587206 |
| nsc 108930 |
| Q27279397 |
| 5,6-diethoxybenzo[b]thiophene-2-carboxylic acid |
Research Excerpts
Dosage Studied
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |